Gregory M Ross

Gregory M Ross is a notable inventor based in Kingston, CA. He has made significant contributions to the field of neurotrophin research, holding a total of 6 patents. His work focuses on innovative methods to inhibit neurotrophin-receptor binding, which has implications for understanding nerve growth and related disorders.

Latest Patents

One of Gregory M Ross's latest patents is a method of inhibiting neurotrophin-receptor binding. This invention relates to compositions that inhibit the binding of nerve growth factor to the p75 common neurotrophin receptor. The patent outlines a compound that, when bound to nerve growth factor, includes at least two of the following: a first electronegative atom or functional group, a second electronegative atom or functional group, a third electronegative atom or functional group, a fourth electronegative atom or functional group, and a hydrophobic moiety that interacts with the hydrophobic region formed by specific amino acids of nerve growth factor.

Career Highlights

Gregory M Ross is affiliated with Queen's University at Kingston, where he conducts his research and development. His work has been instrumental in advancing the understanding of neurotrophin interactions and their potential therapeutic applications.

Collaborations

Throughout his career, Gregory has collaborated with esteemed colleagues such as Richard J Riopelle and Donald F Weaver. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Gregory M Ross is a prominent figure in neurotrophin research, with a focus on innovative methods to inhibit receptor binding. His contributions through patents and collaborations continue to impact the scientific community and pave the way for future advancements in this important area of study.